Skip to Content

Home
About
Our Science
Programs & Pipeline
- Pipeline
- Clinical Trials
Patient Focus
- Patient Stories
- Disease Focus
Investors & Media

Careers
Contact

menu

Glossary

Repair

Correction of “misspelled” disease-driving DNA sequence using a CRISPR/Cas9-based gene editing therapy.

Cookie Policy
Terms of Use
Privacy Notice for HCPs
Privacy Policy

© 2026. Intellia Therapeutics, Inc.

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.

You are leaving the
Intellia Therapeutics, Inc. website.

You may return to the Intellia Therapeutics, Inc. website by closing the window to the third-party website you have opened. Do you wish to continue?

When you are ready to return to the Intellia Therapeutics, Inc. website, simply close the window to the third-party website you have opened.

Yes No